Rui Qiang, Li Chuyu, Rui Yiqi, Zhang Chuanzhuo, Xia Cunbing, Wang Qing, Liu Yuanyuan, Wang Peng
Department of General Surgery, Jiangsu Province Hospital of Chinese Medicine, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, 210029, China.
State Key Laboratory of Reproductive Medicine, Center of Clinical Reproductive Medicine, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, 210029, China.
Stem Cell Res Ther. 2024 Dec 20;15(1):491. doi: 10.1186/s13287-024-04094-4.
Chronic atrophic gastritis (CAG) is a chronic disease of the gastric mucosa characterized by a reduction or an absolute disappearance of the original gastric glands, possibly replaced by pseudopyloric fibrosis, intestinal metaplasia, or fibrosis. CAG develops progressively into intestinal epithelial metaplasia, dysplasia, and ultimately, gastric cancer. Epidemiological statistics have revealed a positive correlation between the incidence of CAG and age. Mesenchymal stem cells (MSCs) are a type of adult stem cells derived from mesoderm, with strong tissue repair capabilities. Therefore, the restoration of the gastric mucosa may serve as an efficacious strategy to ameliorate CAG and avert gastric cancer. However, the mechanisms by which MSCs inhibit the relentless progression of aging atrophic gastritis remain to be elucidated. This study endeavored to assess a novel approach utilizing MSCs to treat CAG and forestall carcinogenics.
In this study, we selected mice with atrophic gastritis from naturally aging mice and administered human umbilical cord-derived mesenchymal stem cells (hUMSCs) via tail vein injection to evaluate the therapeutic effects of hUMSCs on age-related chronic atrophic gastritis. Initially, we employed methods such as ELISA, immunohistochemical analysis, and TUNEL assays to detect changes in the mice post-hUMSC injection. Proteomic and bioinformatics analyses were conducted to identify differentially expressed proteins, focusing on NADH: ubiquinone oxidoreductase core subunit S8 (Ndufs8). Co-culturing hUMSCs with Ndufs8 knockout gastric mucosal epithelial cells (GMECs), we utilized flow cytometry, Western blotting, real-time quantitative PCR, and immunofluorescence to investigate the mechanisms of action of hUMSCs.
We observed that hUMSCs are capable of migrating to and repairing damaged gastric mucosa. Initially, hUMSCs significantly enhanced the secretion of gastric proteins PG-1 and G17, while concurrently reducing inflammatory cytokines. Furthermore, hUMSCs mitigated gastric fibrosis and apoptosis in mucosal cells. Proteomic and bioinformatic analyses revealed alterations in the protein network involved in mitochondrial autophagy, with Ndufs8 playing a pivotal role. Upon knocking out Ndufs8 in GMECs, we noted mitochondrial damage and reduced autophagy, leading to an aged phenotype in GMECs. Co-culturing Ndufs8-knockout GMECs with hUMSCs demonstrated that hUMSCs could ameliorate mitochondrial dysfunction and restore the cell cycle in GMECs.
慢性萎缩性胃炎(CAG)是一种胃黏膜慢性疾病,其特征为原有胃腺减少或完全消失,可能被假幽门腺化生、肠化生或纤维化所取代。CAG会逐渐发展为肠上皮化生、发育异常,并最终发展为胃癌。流行病学统计显示CAG的发病率与年龄呈正相关。间充质干细胞(MSCs)是一种来源于中胚层的成体干细胞,具有强大的组织修复能力。因此,修复胃黏膜可能是改善CAG和预防胃癌的有效策略。然而,MSCs抑制萎缩性胃炎持续进展的机制仍有待阐明。本研究致力于评估一种利用MSCs治疗CAG并预防癌变的新方法。
在本研究中,我们从自然衰老的小鼠中选择患有萎缩性胃炎的小鼠,并通过尾静脉注射给予人脐带间充质干细胞(hUMSCs),以评估hUMSCs对与年龄相关的慢性萎缩性胃炎的治疗效果。最初,我们采用酶联免疫吸附测定(ELISA)、免疫组织化学分析和末端脱氧核苷酸转移酶介导的缺口末端标记(TUNEL)测定等方法来检测hUMSCs注射后小鼠的变化。进行蛋白质组学和生物信息学分析以鉴定差异表达的蛋白质,重点关注烟酰胺腺嘌呤二核苷酸(NADH):泛醌氧化还原酶核心亚基S8(Ndufs8)。将hUMSCs与Ndufs8基因敲除的胃黏膜上皮细胞(GMECs)共培养,我们利用流式细胞术、蛋白质免疫印迹法、实时定量聚合酶链反应(PCR)和免疫荧光来研究hUMSCs的作用机制。
我们观察到hUMSCs能够迁移至受损的胃黏膜并进行修复。最初,hUMSCs显著增强了胃蛋白酶原-1(PG-1)和胃泌素17(G17)的分泌,同时减少了炎性细胞因子。此外,hUMSCs减轻了胃纤维化和黏膜细胞凋亡。蛋白质组学和生物信息学分析揭示了参与线粒体自噬的蛋白质网络发生了改变,其中Ndufs8起关键作用。在GMECs中敲除Ndufs8后,我们注意到线粒体损伤和自噬减少,导致GMECs出现衰老表型。将Ndufs8基因敲除的GMECs与hUMSCs共培养表明,hUMSCs可以改善线粒体功能障碍并恢复GMECs的细胞周期。